Join IDEAYA Biosciences for a virtual Investor R&D day featuring GSK and a KOL, showcasing scientific insights and clinical development…

Join Immix Biopharma and key opinion leaders Heather Landau, MD (Director of Amyloidosis Program, Memorial Sloan-Kettering Cancer Center), Vaishali Sanchorawala, MD (Professor,…
Join us for a virtual KOL event to discuss new data from the ongoing Phase 2 ReSPECT-GBM trial of rhenium…
Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…
Join us for a virtual KOL event with ALIGOS Therapeutics, featuring Mark Sulkowski, MD (Johns Hopkins University School of Medicine)…
Join us for an evening of networking, cocktails, and hors d'oeuvres hosted by LifeSci Partners during the Jefferies London Healthcare…
Join Arrowhead Pharmaceuticals for a virtual analyst and investor event reviewing the new Phase 2 clinical data from the ongoing…
View the webcast here.
The event will focus on the therapeutic potential of VYNE's novel and proprietary InhiBETTM platform of its bromodomain and extra-terminal…
Join us virtually via webcast, for a KOL event featuring Prof. Victor Villemagne, MD (University of Pittsburgh), to discuss the heightened…
View the webcast here.

Join us for a virtual KOL event featuring Fiona Simpkins, MD (Perelman School of Medicine, University of Pennsylvania) and Timothy A. Yap, MBBS,…
Join us for a virtual clinical update with Aptose Biosciences and featuring two respected KOLs. The webcast event will include…
BriaCell Virtual KOL Event Agenda – October 26, 2023 Dr. William Williams (CEO) – Introduction and opening remarks Dr. Giuseppe…
Join us for a virtual KOL event with Gradalis, featuring Rodney P. Rocconi, MD (Director, Cancer Center & Research Institute and…
Join Skye Bioscience for a virtual Investor Day featuring Brian Levy, O.D. (former CMO, Aerie and Bausch & Lomb), Glenwood Gum,…